1-20 of 174
Brian K. Link
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis

Brooj Abro, Matthew J. Maurer, Thomas M. Habermann, W. Richard Burack, Jennifer R. Chapman, Jonathon B. Cohen, Jonathan W. Friedberg, Giorgio Inghirami, Brad S. Kahl, Melissa C. Larson, Brian K. Link, Izidore S. Lossos, Peter Martin, Timothy J. McDonnell, Loretta J. Nastoupil, Shaun M. Riska, Sergei Syrbu, Francisco Vega, Kiran R. Vij, Christopher R. Flowers, James R. Cerhan, David L. Jaye, Andrew L. Feldman
Journal: Blood
Blood (2024) 144 (19): 2063–2066.
https://doi.org/10.1182/blood.2024025681
Published: 2024
Includes: Supplemental data
Journal Articles

Comparing Clinical Characteristics and Outcomes of MYC and BCL6 Double Hit Lymphoma (DHL- BCL6 ) with Other Aggressive B-Cell Lymphomas: Understanding the Impact of New Who and International Consensus Classifications

Arushi Khurana, Raphael Mwangi, James R. Cerhan, Jonathon B. Cohen, Jennifer R. Chapman-Fredricks, Jonathan W. Friedberg, Christopher R. Flowers, Richard Burack, Izidore S. Lossos, Loretta J. Nastoupil, Andrew L. Feldman, Brad S. Kahl, Peter Martin, Grzegorz S. Nowakowski, Brian K. Link, Timothy J. McDonnell, Giorgio Inghirami, Sergei Syrbu, Kiran R. Vij, Matthew J. Maurer, Thomas M. Habermann, Rebecca L. King
Journal: Blood
Blood (2023) 142 (Supplement 1): 67.
https://doi.org/10.1182/blood-2023-190316
Published: 2023
Journal Articles

Multicenter Study of Mantle Cell Lymphoma Outcomes Following First-Line Bendamustine-Rituximab and Second-Line Bruton's Tyrosine Kinase Inhibitor Therapy

Yucai Wang, Melissa C. Larson, Steven R. Hwang, Anita Kumar, Ashlee Joseph, Brian T. Hill, Taylor R. Brooks, David A. Bond, Kami J. Maddocks, Alexey Danilov, Christine McCarthy, Jia Ruan, Imran A. Nizamuddin, Brad S. Kahl, Natalie S. Grover, Nazneen B. Khan, Evguenia Ouchveridze, Aung M. Tun, Philip Young, Craig A. Portell, Zoey I. Harris, Javier L. Munoz, Patrick M. Reagan, Georgio Pongas, Izidore S. Lossos, Christine E. Ryan, Reid W. Merryman, Firas Baidoun, Muhamad Alhaj Moustafa, Drew Gerber, Sabarish R. Ayyappan, Brian K. Link, Arash Velayati, Irl Brian Greenwell, Lauren G Banaszak, Priyanka A Pophali, Anthony C. Stack, Marcus R. Messmer, Mayur Narkhede, Amitkumar N. Mehta, Preetesh Jain, Michael L. Wang, Tamara K. Moyo, Nilanjan Ghosh, Rahul S. Bhansali, Stefan K. Barta, Manali K. Kamdar, Jacob Anna, Alexander V. Stanisic, Reem Karmali, Laveniya Kugathasan, Diego Villa, Matthew J. Maurer, James R. Cerhan, Jonathon B. Cohen, Peter Martin
Journal: Blood
Blood (2023) 142 (Supplement 1): 300.
https://doi.org/10.1182/blood-2023-182942
Published: 2023
Journal Articles

The FLIPI24 Prognostic Model Identifies Poor Outcomes in Non-Immunochemotherapy Treated Patients with Follicular Lymphoma

Carla Casulo, Melissa C. Larson, Christopher R. Flowers, Thomas M. Habermann, Thomas E. Witzig, Yucai Wang, Grzegorz S. Nowakowski, Andrew L. Feldman, Loretta J. Nastoupil, Dai Chihara, Richard Burack, Jonathan R Day, Urshila Durani, Peter Martin, Jonathon B. Cohen, Jonathan W. Friedberg, Izidore S. Lossos, Brad S. Kahl, Brian K. Link, James R. Cerhan, Matthew J. Maurer
Journal: Blood
Blood (2023) 142 (Supplement 1): 1657.
https://doi.org/10.1182/blood-2023-186684
Published: 2023
Journal Articles

Improvements in Overall Survival in Older Patients with Mantle Cell Lymphoma Are Driven By Improvements across Multiple Lines of Therapy

Danny Luan, Neela Easwar, Zhengming Chen, Brian K. Link, Yucai Wang, Matthew J. Maurer, Brad S. Kahl, Laura Pinheiro, John P. Leonard, Peter Martin
Journal: Blood
Blood (2023) 142 (Supplement 1): 1664.
https://doi.org/10.1182/blood-2023-184807
Published: 2023
Journal Articles

Tumor Mutational Burden As a Prognostic Factor in Diffuse Large B-Cell Lymphoma

Rosalie Griffin, Kerstin Wenzl, Vivekananda Sarangi, Lisa M. Rimsza, Rebecca King, Andrew L. Feldman, Matthew J. Maurer, Grzegorz S. Nowakowski, Brian K. Link, Thomas M. Habermann, Nicholas Stong, C. Chris Huang, Anita K. Gandhi, Susan L. Slager, Anne J. Novak, James R. Cerhan
Journal: Blood
Blood (2023) 142 (Supplement 1): 1633.
https://doi.org/10.1182/blood-2023-182291
Published: 2023
Journal Articles

Ki-67 Expression of 50% Is the Optimal Cut-Off to Predict Survival Outcomes in Mantle Cell Lymphoma (MCL): A Pooled Analysis from CALGB 50403 (Alliance) and MCL Real-World Study Cohort

Narendranath Epperla, Jeffrey M. Switchenko, Susan M. Geyer, Veronika Bachanova, Stefan K. Barta, Alexey Danilov, Natalie S. Grover, Reem Karmali, Brian T. Hill, Nilanjan Ghosh, Timothy S. Fenske, Peter Martin, Brad S. Kahl, Christopher R. Flowers, Brian K. Link, Eric D. Hsi, Kami J. Maddocks, Kristie A. Blum, Thomas M. Habermann, Matthew J. Maurer, Lawrence David Kaplan, Nancy L. Bartlett, John P. Leonard, Jonathon B. Cohen
Journal: Blood
Blood (2023) 142 (Supplement 1): 380.
https://doi.org/10.1182/blood-2023-189505
Published: 2023
Journal Articles

Development and Validation of the Early-Stage Hodgkin Lymphoma (HL) International Prognostication Index (E-HIPI): A Report from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium

Andrew M Evens, Angie Mae Rodday, Matthew J. Maurer, Ranjana H. Advani, Marc Andre, Andrea Gallamini, Annette E. Hay, David Hodgson, Richard T. Hoppe, Martin Hutchings, Peter Johnson, Brian K. Link, Stephen Opat, John M. Raemaekers, Jenica Upshaw, Qingyan Xiang, Nicholas Counsell, Susan K Parsons, John Radford
Journal: Blood
Blood (2023) 142 (Supplement 1): 3058.
https://doi.org/10.1182/blood-2023-173320
Published: 2023
Journal Articles

Diagnosis to Treatment Interval (DTI) Informs Outcomes across Subtypes of Aggressive B-Cell Lymphoma

Matthew J. Maurer, Arushi Khurana, Raphael Mwangi, Grzegorz S. Nowakowski, Carla Casulo, Dai Chihara, Jonathon B. Cohen, Brad S. Kahl, Izidore S. Lossos, Peter Martin, Yucai Wang, Timothy J. McDonnell, Andrew L. Feldman, David L Jaye, Thomas M. Habermann, James R. Cerhan, Christopher R. Flowers, Brian K. Link, Loretta J. Nastoupil
Journal: Blood
Blood (2023) 142 (Supplement 1): 3123.
https://doi.org/10.1182/blood-2023-174715
Published: 2023
Journal Articles

Ilyad: A Phase III Double Blind, Randomized Trial Evaluating Vitamin D (Cholecalciferol) in Patients with Low Tumor-Burden Indolent Non-Hodgkin Lymphoma Treated with Rituximab Therapy

Jonathan W. Friedberg, Michael T. Brady, Strawderman Myla, Brad S. Kahl, Izidore S. Lossos, Jonathon B. Cohen, Patrick M. Reagan, Carla Casulo, Barbara L. Averill, Brian K. Link, Paul M. Barr, John P. Leonard, John M. Ashton, Derick R Peterson, Loretta J. Nastoupil
Journal: Blood
Blood (2023) 142 (Supplement 1): 606.
https://doi.org/10.1182/blood-2023-178088
Published: 2023
Journal Articles

Impact of Frontline Treatment Strategy on Quality of Life in the First Decade after a Diagnosis of Marginal Zone Lymphoma

Côme Bommier, Mazie Tsang, Brie N. Noble, Carrie Thompson, Christopher Strouse, Carla Casulo, Eric Mou, Melissa C. Larson, Brianna Gysbers, Allison C. Rosenthal, Andrew L. Feldman, Matthew J. Maurer, Kathleen Yost, Susan L. Slager, Brian K. Link, Thomas M. Habermann, Amylou Constance Dueck, James R. Cerhan
Journal: Blood
Blood (2023) 142 (Supplement 1): 2394.
https://doi.org/10.1182/blood-2023-186862
Published: 2023
Journal Articles

Longitudinal Analysis of Patient Reported Quality of Life in Newly Diagnosed Chronic Lymphocytic Leukemia Stratified By Initial Management Strategy: A Multi-Institutional Prospective Cohort Study

Amber Koehler, Brie N. Noble, Timothy G. Call, Sameer A. Parikh, Tait D. Shanafelt, Mazie Tsang, Côme Bommier, Kari G. Rabe, Christopher Strouse, Carrie Thompson, Paul J. Hampel, Kathleen Yost, Melissa C. Larson, Susan L. Slager, Brian K. Link, James R. Cerhan, Amylou Constance Dueck
Journal: Blood
Blood (2023) 142 (Supplement 1): 498.
https://doi.org/10.1182/blood-2023-187268
Published: 2023
Journal Articles

DEK Regulates B-Cell Proliferative Capacity and Is Associated with Aggressive Disease in Low-Grade B-Cell Lymphoma

Melissa A. Hopper, Abigail R. Dropik, Janek S. Walker, Joseph P. Novak, Miranda S. Laverty, Michelle Manske, Xiaosheng Wu, Kerstin Wenzl, Jordan Edward Krull, Vivekananda Sarangi, Matthew J. Maurer, Thomas M. Habermann, Brian K. Link, Lisa M. Rimsza, Thomas E. Witzig, Stephen M Ansell, James R. Cerhan, Dragan Jevremovic, Anne J. Novak
Journal: Blood
Blood (2023) 142 (Supplement 1): 4360.
https://doi.org/10.1182/blood-2023-180232
Published: 2023
Journal Articles

Molecular Classification of Relapsed DLBCL Reveals Novel Biologic Subgroups

Kerstin Wenzl, Matthew E Stokes, Joseph P. Novak, Allison M. Bock, Melissa A. Hopper, Jordan Krull, Abigail R. Dropik, Janek S. Walker, Miranda S. Laverty, Vivekananda Sarangi, Raphael Mwangi, Maria Ortiz, Nicholas Stong, C. Chris Huang, Matthew J. Maurer, Lisa M. Rimsza, Brian K. Link, Rebecca King, Stephen M Ansell, Thomas M. Habermann, Thomas E. Witzig, Grzegorz S. Nowakowski, James R. Cerhan, Anita K. Gandhi, Anne J. Novak
Journal: Blood
Blood (2023) 142 (Supplement 1): 2770.
https://doi.org/10.1182/blood-2023-180949
Published: 2023
Journal Articles

Patterns of Care and Prognostic Modeling Following Follicular Lymphoma Transformation to Aggressive B-Cell Lymphoma: An Analysis from the LEO Consortium

Jonathan R Day, Melissa C. Larson, Carla Casulo, Urshila Durani, Yucai Wang, Dai Chihara, Loretta J. Nastoupil, Brad S. Kahl, Peter Martin, Izidore S. Lossos, Jason T. Romancik, Amy Ayers, Richard Burack, Thomas M. Habermann, James R. Cerhan, Christopher R. Flowers, Matthew J. Maurer, Brian K. Link
Journal: Blood
Blood (2023) 142 (Supplement 1): 3111.
https://doi.org/10.1182/blood-2023-179650
Published: 2023
Journal Articles

An International Multicohort Study of Conditional Survival and Cause of Death after Achieving Event-Free Survival at 24 Months in Patients with Mantle Cell Lymphoma

Yucai Wang, Melissa C. Larson, Umar Farooq, Sara Ekberg, Karin Ekstroem Smedby, Mikkel Runason Simonsen, Carsten Utoft Niemann, Eric J. Zhao, Alina S. Gerrie, Jeffrey M. Switchenko, David A. Bond, Veronika Bachanova, Stefan K. Barta, Brian T. Hill, Peter Martin, Alexey Danilov, Natalie S. Grover, Reem Karmali, Nilanjan Ghosh, Timothy S. Fenske, Brad S. Kahl, Alexandra Albertsson-Lindblad, Ingrid Cecilia Glimelius, Ahmed Ludvigsen Al-Mashhadi, Thomas Stauffer Larsen, Kami J. Maddocks, Brian K. Link, Jonas Paludo, Grzegorz S. Nowakowski, Thomas M. Habermann, Matthew J. Maurer, Diego Villa, Jonathon B. Cohen, Tarec Christoffer Christoffer El-Galaly, Mats Jerkeman, James R. Cerhan
Journal: Blood
Blood (2023) 142 (Supplement 1): 1656.
https://doi.org/10.1182/blood-2023-182747
Published: 2023
Journal Articles

Identification of Risk Categories from the Advanced-Stage Hodgkin International Prognostic Index (A-HIPI) Model: A Detailed Analysis from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium

Matthew J. Maurer, Susan K Parsons, Jenica Upshaw, Jonathan W. Friedberg, Andrea Gallamini, Massimo Federico, Eliza A Hawkes, David Hodgson, Peter Johnson, Brian K. Link, Kerry J. Savage, Pier Luigi Zinzani, Andrew M Evens
Journal: Blood
Blood (2023) 142 (Supplement 1): 3067.
https://doi.org/10.1182/blood-2023-175079
Published: 2023
Journal Articles

The Presence of Bulky Disease and/or Very High LDH Defines a High-Risk Subset of IPI 1-2 for Eligibility in Clinical Trials of Newly Diagnosed Aggressive B-Cell Lymphoma

Matthew J. Maurer, Arushi Khurana, Umar Farooq, Jason T. Romancik, Jonathan W. Friedberg, Izidore S. Lossos, Brad S. Kahl, Peter Martin, Dai Chihara, Andrew L. Feldman, Sergei Syrbu, David L Jaye, Elliot Cahn, Thomas M. Habermann, Brian K. Link, James R. Cerhan, Christopher R. Flowers, Loretta J. Nastoupil, Grzegorz S. Nowakowski
Journal: Blood
Blood (2023) 142 (Supplement 1): 4512.
https://doi.org/10.1182/blood-2023-187350
Published: 2023
Journal Articles

Cumulative Incidence, Predictors, and Outcomes of Transformation to Diffuse Large B-Cell Lymphoma in a Prospective Cohort of Patients with Marginal Zone Lymphoma

Côme Bommier, Brian K. Link, Brianna Gysbers, Matthew J. Maurer, Melissa C. Larson, Arushi Khurana, Yucai Wang, Carrie Thompson, Dai Chihara, Juan Pablo Alderuccio, Jean L. Koff, Izidore S. Lossos, Grzegorz S. Nowakowski, Andrew L. Feldman, Thomas M. Habermann, Rebecca L. King, James R. Cerhan
Journal: Blood
Blood (2023) 142 (Supplement 1): 1672.
https://doi.org/10.1182/blood-2023-186626
Published: 2023
Journal Articles

Effectiveness of Chemo-Immunotherapy (CIT) and Novel Therapies in Second or Later Line of Therapy (2L+) for Patients with Relapsed/Refractory (R/R) Aggressive Large B-Cell Lymphoma (LBCL)

Loretta J. Nastoupil, Clark R. Andersen, Amy Ayers, Yucai Wang, Thomas M. Habermann, Dai Chihara, Brad S. Kahl, Brian K. Link, Jonathon B. Cohen, Peter Martin, Izidore S. Lossos, Carla Casulo, Ruitao Lin, Ziyi Li, Melissa C. Larson, Matthew J. Maurer, Lynn Huynh, Chi Gao, Ramya Ramasubramanian, Mei Sheng Duh, Alex Mutebi, Tongsheng Wang, Monika Jun, Anthony Wang, Rajesh Kamalakar, Anupama Kalsekar, James R. Cerhan, Christopher R. Flowers
Journal: Blood
Blood (2023) 142 (Supplement 1): 309.
https://doi.org/10.1182/blood-2023-174497
Published: 2023